↓ Skip to main content

S49. Clinical activity and development of biomarkers for an engineered anti PDL1 antibody MPDL3280A

Overview of attention for article published in Journal for Immunotherapy of Cancer, March 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)

Mentioned by

patent
1 patent
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
S49. Clinical activity and development of biomarkers for an engineered anti PDL1 antibody MPDL3280A
Published in
Journal for Immunotherapy of Cancer, March 2014
DOI 10.1186/2051-1426-2-s2-i21
Authors

E Cha

Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 May 2016.
All research outputs
#8,534,528
of 25,371,288 outputs
Outputs from Journal for Immunotherapy of Cancer
#2,057
of 3,421 outputs
Outputs of similar age
#79,249
of 235,685 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#10
of 17 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,421 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.4. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 235,685 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.